<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34338780</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>26</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>26</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1477-9137</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>134</Volume>
            <Issue>16</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Aug</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of cell science</Title>
          <ISOAbbreviation>J Cell Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A three-dimensional spheroid-specific role for Wnt-β-catenin and Eph-ephrin signaling in nasopharyngeal carcinoma cells.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">jcs256461</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1242/jcs.256461</ELocationID>
        <Abstract>
          <AbstractText>One of the greatest unmet needs hindering the successful treatment of nasopharyngeal carcinomas (NPCs) is for representative physiological and cost-effective models. Although Epstein-Barr virus (EBV) infection is consistently present in NPCs, most studies have focused on EBV-negative NPCs. For the first time, we established and analyzed three-dimensional (3D) spheroid models of EBV-positive and EBV-negative NPC cells and compared these to classical two-dimensional (2D) cultures in various aspects of tumor phenotype and drug responses. Compared to 2D monolayers, the 3D spheroids showed significant increases in migration capacity, stemness characteristics, hypoxia and drug resistance. Co-culture with endothelial cells, which mimics essential interactions in the tumor microenvironment, effectively enhanced spheroid dissemination. Furthermore, RNA sequencing revealed significant changes at the transcriptional level in 3D spheroids compared to expression in 2D monolayers. In particular, we identified known (VEGF, AKT and mTOR) and novel (Wnt-β-catenin and Eph-ephrin) cell signaling pathways that are activated in NPC spheroids. Targeting these pathways in 3D spheroids using FDA-approved drugs was effective in monoculture and co-culture. These findings provide the first demonstration of the establishment of EBV-positive and EBV-negative NPC 3D spheroids with features that resemble advanced and metastatic NPCs. Furthermore, we show that NPC spheroids have potential use in identifying new drug targets.</AbstractText>
          <CopyrightInformation>© 2021. Published by The Company of Biologists Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yi</LastName>
            <ForeName>Canhui</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>School of Biological Sciences, University of Hong Kong, Pokfulam Road, Hong Kong.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lai</LastName>
            <ForeName>Sook Ling</ForeName>
            <Initials>SL</Initials>
            <AffiliationInfo>
              <Affiliation>School of Biological Sciences, University of Hong Kong, Pokfulam Road, Hong Kong.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tsang</LastName>
            <ForeName>Chi Man</ForeName>
            <Initials>CM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomical and Cellular Pathology and State Key Laboratory of Translational Oncology, Chinese University of Hong Kong, Shatin, Hong Kong.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Artemenko</LastName>
            <ForeName>Margarita</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>School of Biological Sciences, University of Hong Kong, Pokfulam Road, Hong Kong.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shuen Tang</LastName>
            <ForeName>Maggie Kei</ForeName>
            <Initials>MK</Initials>
            <AffiliationInfo>
              <Affiliation>School of Biological Sciences, University of Hong Kong, Pokfulam Road, Hong Kong.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Laboratory for Synthetic Chemistry and Chemical Biology Limited, 17W, Hong Kong Science and Technology Parks, New Territories, Hong Kong.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pang</LastName>
            <ForeName>Stella W</ForeName>
            <Initials>SW</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Electronic Engineering, City University of Hong Kong, Kowloon, Hong Kong.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Centre for Biosystems, Neuroscience, and Nanotechnology, City University of Hong Kong, Kowloon, Hong Kong.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lo</LastName>
            <ForeName>Kwok Wai</ForeName>
            <Initials>KW</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Anatomical and Cellular Pathology and State Key Laboratory of Translational Oncology, Chinese University of Hong Kong, Shatin, Hong Kong.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tsao</LastName>
            <ForeName>Sai Wah</ForeName>
            <Initials>SW</Initials>
            <AffiliationInfo>
              <Affiliation>School of Biomedical Sciences, University of Hong Kong, Sassoon Road, Hong Kong.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wong</LastName>
            <ForeName>Alice Sze Tsai</ForeName>
            <Initials>AST</Initials>
            <Identifier Source="ORCID">0000-0002-0676-6475</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Biological Sciences, University of Hong Kong, Pokfulam Road, Hong Kong.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>08</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Cell Sci</MedlineTA>
        <NlmUniqueID>0052457</NlmUniqueID>
        <ISSNLinking>0021-9533</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D036342">Ephrins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051176">beta Catenin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D036342" MajorTopicYN="N">Ephrins</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020031" MajorTopicYN="Y">Epstein-Barr Virus Infections</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004854" MajorTopicYN="N">Herpesvirus 4, Human</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000077274" MajorTopicYN="N">Nasopharyngeal Carcinoma</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009303" MajorTopicYN="Y">Nasopharyngeal Neoplasms</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059016" MajorTopicYN="N">Tumor Microenvironment</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051176" MajorTopicYN="N">beta Catenin</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">2D monolayer</Keyword>
        <Keyword MajorTopicYN="Y">3D spheroids</Keyword>
        <Keyword MajorTopicYN="Y">Drug response</Keyword>
        <Keyword MajorTopicYN="Y">Microenvironment</Keyword>
        <Keyword MajorTopicYN="Y">Nasopharyngeal carcinoma</Keyword>
      </KeywordList>
      <CoiStatement>Competing interests The authors declare no competing or financial interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>2</Day>
          <Hour>12</Hour>
          <Minute>26</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34338780</ArticleId>
        <ArticleId IdType="doi">10.1242/jcs.256461</ArticleId>
        <ArticleId IdType="pii">271163</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
